EBP1 has previously been implicated to have tumour suppressor properties in different cancer types including salivary adenoid cystic and hepatocellular carcinoma (HCC), as well as prostate and breast cancer [70–73]. This evidence concerns the gene PA2G4 and breast carcinoma.